M&A Deal Summary

Great Point Partners Acquires JPA Health

On May 4, 2022, private equity firm Great Point Partners acquired marketing company JPA Health

Acquisition Highlights
  • This is Great Point Partners’ 1st transaction in the Marketing sector.
  • This is Great Point Partners’ 25th transaction in the United States.
  • This is Great Point Partners’ 1st transaction in District of Columbia.

M&A Deal Summary
Date 2022-05-04
Target JPA Health
Sector Marketing
Buyer(s) Great Point Partners
Deal Type Recapitalization

Target

JPA Health

Washington, District of Columbia, United States
JPA Health is an independent, full-service agency that provides marketing, public relations, and advocacy services. The company works with many healthcare companies, NGOs, and federal government agencies. JPA Health was formed in 2007 and is based in Washington, District of Columbia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Great Point Partners

Greenwich, Connecticut, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2003
PE ASSETS 1.7B USD
Size Large
Type Sector Focused
DESCRIPTION

Great Point Partners is a private investment firm focused on investing in private and public healthcare companies. Great Point's private equity practice invests $10 to $100 million of growth capital in private, growing companies. Specific areas of interest within the healthcare sector includes biotechnology and life sciences, consumer health, generic drugs, health care services, information technology, insurance, medical devices, specialty pharmaceuticals, and worker compensation companies. Great Point Partners was formed in 2003 and is based in Greenwich, Connecticut.

DEAL STATS #
Overall 31 of 35
Sector (Marketing) 1 of 1
Type (Recapitalization) 14 of 15
State (District of Columbia) 1 of 1
Country (United States) 25 of 28
Year (2022) 3 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-11 Cellipont Bioservices

The Woodlands, Texas, United States

Cellipont Bioservices is a contract and development manufacturing organization (“CDMO”) of cell therapy products for biopharmaceutical companies. The company leverages its world-class expertise in cell manufacturing and master cell banks, regulatory track record, and technical expertise to maintain a leading position as a global CDMO focused on cell therapy. Cellipont Bioservices was formed in 2002 and is based in The Woodlands, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-01 SteriPack

Mullingar, Ireland

SteriPack is a contract manufacturing and value-added service provider to the medical device and pharmaceutical (primarily drug-device combination products) industries. Serving some of the largest names in the medical device industry, the Company has experienced impressive customer retention and provides the highest quality and customer service. SteriPack is headquartered in Mullingar, Ireland.

Sell -
Mergr

Product

Company

Legal